Literature DB >> 8188379

Identification of a novel antigen from Corynebacterium pseudotuberculosis that protects sheep against caseous lymphadenitis.

J Walker1, H J Jackson, D G Eggleton, E N Meeusen, M J Wilson, M R Brandon.   

Abstract

A 40-kDa protein antigen from Corynebacterium pseudotuberculosis has been identified by application of a strategy that employs locally derived antibody-secreting cells (ASC). ASC probes generated by culture of ASC obtained from the lymph node draining the site of infection showed a specificity restricted to a 40-kDa antigen. Analysis of immunoblots with sequential serum samples taken from sheep during the course of experimental primary infection with C. pseudotuberculosis also revealed the 40-kDa antigen as an early immunodominant antigen. Sheep vaccinated with two 100-micrograms doses of a 40-kDa antigen preparation in aluminium hydroxide adjuvant were protected against infection with C. pseudotuberculosis, with an 82% reduction in the proportion of infected sheep and a 98% reduction in lung lesions. Sera from vaccinated sheep exhibited a strong response only to the 40-kDa antigen on immunoblots. These results strongly suggest that the 40-kDa antigen plays a major role in immunity to caseous lymphadenitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188379      PMCID: PMC186545          DOI: 10.1128/iai.62.6.2562-2567.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Mr 26,000 antigen of Schistosoma japonicum recognized by resistant WEHI 129/J mice is a parasite glutathione S-transferase.

Authors:  D B Smith; K M Davern; P G Board; W U Tiu; E G Garcia; G F Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Relation of lipid content and exotoxin production to virulence of Corynebacterium pseudotuberculosis in mice.

Authors:  C A Muckle; C L Gyles
Journal:  Am J Vet Res       Date:  1983-06       Impact factor: 1.156

3.  Cloning and expression of a species-specific early immunogenic 36-kilodalton protein of Mycoplasma hyopneumoniae in Escherichia coli.

Authors:  M Strasser; J Frey; G Bestetti; M Kobisch; J Nicolet
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

4.  Identification of antigens of Mycobacterium tuberculosis using human monoclonal antibodies.

Authors:  R S Wallis; S L Alde; D V Havlir; M H Amir-Tahmasseb; T M Daniel; J J Ellner
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Antigen specificity of antibody responses to Corynebacterium pseudotuberculosis in naturally infected sheep with caseous lymphadenitis.

Authors:  J A Ellis; D A Hawk; K W Mills; D L Pratt
Journal:  Vet Immunol Immunopathol       Date:  1991-07       Impact factor: 2.046

6.  Immunisation against ovine caseous lymphadenitis: comparison of Corynebacterium pseudotuberculosis vaccines with and without bacterial cells.

Authors:  D G Eggleton; H D Middleton; C V Doidge; D W Minty
Journal:  Aust Vet J       Date:  1991-10       Impact factor: 1.281

7.  Antigen specificity and activity of ovine antibodies induced by immunization with Corynebacterium pseudotuberculosis culture filtrate.

Authors:  J A Ellis; D A Hawk; K W Mills; D L Pratt
Journal:  Vet Immunol Immunopathol       Date:  1991-07       Impact factor: 2.046

8.  Identification of two integral membrane proteins of Plasmodium falciparum.

Authors:  J A Smythe; R L Coppel; G V Brown; R Ramasamy; D J Kemp; R F Anders
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Effect of muramyl dipeptide on immunogenicity of Corynebacterium pseudotuberculosis whole-cell vaccines in mice and lambs.

Authors:  K A Brogden; L Chedid; R C Cutlip; H D Lehmkuhl; J Sacks
Journal:  Am J Vet Res       Date:  1990-02       Impact factor: 1.156

10.  Lymphocyte subpopulations in pyogranulomas of caseous lymphadenitis.

Authors:  J Walker; H Jackson; M R Brandon; E Meeusen
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

View more
  15 in total

1.  Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep.

Authors:  P J Chaplin; R De Rose; J S Boyle; P McWaters; J Kelly; J M Tennent; A M Lew; J P Scheerlinck
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep.

Authors:  C P Simmons; S J Dunstan; M Tachedjian; J Krywult; A L Hodgson; R A Strugnell
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

3.  Molecular and biochemical characterization of a protective 40-kilodalton antigen from Corynebacterium pseudotuberculosis.

Authors:  M J Wilson; M R Brandon; J Walker
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

4.  A combined approach for comparative exoproteome analysis of Corynebacterium pseudotuberculosis.

Authors:  Luis G C Pacheco; Susan E Slade; Núbia Seyffert; Anderson R Santos; Thiago L P Castro; Wanderson M Silva; Agenor V Santos; Simone G Santos; Luiz M Farias; Maria A R Carvalho; Adriano M C Pimenta; Roberto Meyer; Artur Silva; James H Scrivens; Sérgio C Oliveira; Anderson Miyoshi; Christopher G Dowson; Vasco Azevedo
Journal:  BMC Microbiol       Date:  2011-01-17       Impact factor: 3.605

5.  The complete genome sequence of Corynebacterium pseudotuberculosis FRC41 isolated from a 12-year-old girl with necrotizing lymphadenitis reveals insights into gene-regulatory networks contributing to virulence.

Authors:  Eva Trost; Lisa Ott; Jessica Schneider; Jasmin Schröder; Sebastian Jaenicke; Alexander Goesmann; Peter Husemann; Jens Stoye; Fernanda Alves Dorella; Flavia Souza Rocha; Siomar de Castro Soares; Vívian D'Afonseca; Anderson Miyoshi; Jeronimo Ruiz; Artur Silva; Vasco Azevedo; Andreas Burkovski; Nicole Guiso; Olivier F Join-Lambert; Samer Kayal; Andreas Tauch
Journal:  BMC Genomics       Date:  2010-12-30       Impact factor: 3.969

6.  Comparative analysis of two complete Corynebacterium ulcerans genomes and detection of candidate virulence factors.

Authors:  Eva Trost; Arwa Al-Dilaimi; Panagiotis Papavasiliou; Jessica Schneider; Prisca Viehoever; Andreas Burkovski; Siomar C Soares; Sintia S Almeida; Fernanda A Dorella; Anderson Miyoshi; Vasco Azevedo; Maria P Schneider; Artur Silva; Cíntia S Santos; Louisy S Santos; Priscila Sabbadini; Alexandre A Dias; Raphael Hirata; Ana L Mattos-Guaraldi; Andreas Tauch
Journal:  BMC Genomics       Date:  2011-07-30       Impact factor: 3.969

Review 7.  Progression of 'OMICS' methodologies for understanding the pathogenicity of Corynebacterium pseudotuberculosis: the Brazilian experience.

Authors:  Fernanda A Dorella; Alfonso Gala-Garcia; Anne C Pinto; Boutros Sarrouh; Camila A Antunes; Dayana Ribeiro; Flavia F Aburjaile; Karina K Fiaux; Luis C Guimarães; Núbia Seyffert; Rachid A El-Aouar; Renata Silva; Syed S Hassan; Thiago L P Castro; Wanderson S Marques; Rommel Ramos; Adriana Carneiro; Pablo de Sá; Anderson Miyoshi; Vasco Azevedo; Artur Silva
Journal:  Comput Struct Biotechnol J       Date:  2013-10-13       Impact factor: 7.271

8.  Corynebacterium pseudotuberculosis cp09 mutant and cp40 recombinant protein partially protect mice against caseous lymphadenitis.

Authors:  Judson W Silva; Daniela Droppa-Almeida; Sibele Borsuk; Vasco Azevedo; Ricardo W Portela; Anderson Miyoshi; Flávia S Rocha; Fernanda A Dorella; Wanessa L Vivas; Francine F Padilha; Maria L Hernández-Macedo; Isabel B Lima-Verde
Journal:  BMC Vet Res       Date:  2014-12-20       Impact factor: 2.741

9.  CP40 from Corynebacterium pseudotuberculosis is an endo-β-N-acetylglucosaminidase.

Authors:  Azadeh Shadnezhad; Andreas Naegeli; Mattias Collin
Journal:  BMC Microbiol       Date:  2016-11-08       Impact factor: 3.605

10.  In vivo and in vitro expression of five genes involved in Corynebacterium pseudotuberculosis virulence.

Authors:  Jefferson Ivan Corrêa; Andreas Stocker; Soraya Castro Trindade; Vera Vale; Thais Brito; Bruno Bastos; José Tadeu Raynal; Patrícia Mares de Miranda; Adriano Costa de Alcantara; Songeli Menezes Freire; Lília Moura Costa; Roberto Meyer
Journal:  AMB Express       Date:  2018-05-30       Impact factor: 3.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.